DE69813362D1 - Sulfonylpyrimidine Derivate mit Antitumor Wirkung - Google Patents

Sulfonylpyrimidine Derivate mit Antitumor Wirkung

Info

Publication number
DE69813362D1
DE69813362D1 DE69813362T DE69813362T DE69813362D1 DE 69813362 D1 DE69813362 D1 DE 69813362D1 DE 69813362 T DE69813362 T DE 69813362T DE 69813362 T DE69813362 T DE 69813362T DE 69813362 D1 DE69813362 D1 DE 69813362D1
Authority
DE
Germany
Prior art keywords
derivatives
sulfonylpyrimidine
tumor effects
disulfonyl
cytostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69813362T
Other languages
English (en)
Other versions
DE69813362T2 (de
Inventor
Dr Zinic
Irena Krizmanic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOZYNE D.O.O., ZAGREB, HR
Original Assignee
RUDJER BOSKOVIC INST ZAGREB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RUDJER BOSKOVIC INST ZAGREB filed Critical RUDJER BOSKOVIC INST ZAGREB
Publication of DE69813362D1 publication Critical patent/DE69813362D1/de
Application granted granted Critical
Publication of DE69813362T2 publication Critical patent/DE69813362T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69813362T 1997-05-09 1998-05-07 Sulfonylpyrimidine Derivate mit Antitumor Wirkung Expired - Lifetime DE69813362T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR970239A HRP970239B1 (en) 1997-05-09 1997-05-09 Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity
HR970239 1997-05-09

Publications (2)

Publication Number Publication Date
DE69813362D1 true DE69813362D1 (de) 2003-05-22
DE69813362T2 DE69813362T2 (de) 2004-04-01

Family

ID=10946575

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69813362T Expired - Lifetime DE69813362T2 (de) 1997-05-09 1998-05-07 Sulfonylpyrimidine Derivate mit Antitumor Wirkung

Country Status (7)

Country Link
EP (1) EP0877022B1 (de)
AT (1) ATE237594T1 (de)
CA (1) CA2237267A1 (de)
CZ (1) CZ142498A3 (de)
DE (1) DE69813362T2 (de)
HR (1) HRP970239B1 (de)
PL (1) PL326236A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE325104T1 (de) * 1998-03-30 2006-06-15 Hoffmann La Roche Verfahren zu fabrikation von alpha 1l- adrenorezeptor antagonisten
ES2549379T3 (es) 2008-01-22 2015-10-27 Dow Agrosciences Llc Derivados de 4-amino5-fluoropirimidina como fungicidas
UA112284C2 (uk) 2009-08-07 2016-08-25 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Похідні 5-фторпіримідинону
EA022289B1 (ru) 2009-08-07 2015-12-30 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Производные n1-сульфонил-5-фторпиримидинона
UA106889C2 (uk) 2009-08-07 2014-10-27 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Похідні n1-ацил-5-фторпіримідинону
UA107671C2 (en) 2009-08-07 2015-02-10 Dow Agrosciences Llc N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
EP2521452B1 (de) 2010-01-07 2014-12-24 Dow AgroSciences LLC Thiazol-[5,4-d-]pyrimidine und ihre verwendung als landwirtschaftliche chemikalien
PL2563129T3 (pl) * 2010-04-26 2017-08-31 Adama Makhteshim Ltd N3-podstawione pochodne n1-sulfonylo-5-fluoropirymidynonu
ME02924B (de) 2011-08-17 2018-04-20 Adama Makhteshim Ltd 1-substituierte-5-Fluoro-3,6-dihydro-6-imino-2(1H)-pyrimidinon-Derivate als fungizide Wirkstoffe zur Verwendung im Pflanzenschutz
WO2014105821A1 (en) 2012-12-28 2014-07-03 Dow Agrosciences Llc 1-(substituted-benzoyl)-5-fluoro-4-imino-3-methyl-3,4-dihydropyrimidin-2(1h)-one derivatives
WO2014105844A1 (en) 2012-12-28 2014-07-03 Dow Agrosciences Llc N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1 (2h)-carboxylate derivatives
CN104884062B (zh) 2012-12-28 2018-11-06 阿达玛马克西姆股份有限公司 N-(取代的)-5-氟-4-亚氨基-3-甲基-2-氧代-3,4-二氢嘧啶-1(2h)-甲酰胺衍生物
AU2013370494B2 (en) 2012-12-31 2017-08-17 Adama Makhteshim Ltd. 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1H)-one derivatives as fungicides
CN111362881A (zh) 2013-12-31 2020-07-03 阿达玛马克西姆股份有限公司 一种化合物及其制备方法
NZ722419A (en) 2013-12-31 2018-01-26 Adama Makhteshim Ltd Synergistic fungicidal mixtures and compositions for fungal control

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5324952B2 (de) * 1973-11-28 1978-07-24
JPS51105080A (en) * 1975-03-07 1976-09-17 Mitsui Seiyaku Kogyo Kk 55 furuororashirujudotainoseizohoho
AU523746B2 (en) * 1977-04-05 1982-08-12 Taiho Pharmaceutical Co., Ltd. Anticancer composition
JPS5587777A (en) * 1978-12-27 1980-07-02 Ono Pharmaceut Co Ltd Pyrimidine derivative, its preparation and antitumorigenic agent
JPS6293281A (ja) * 1985-10-17 1987-04-28 Kyowa Hakko Kogyo Co Ltd 抗腫瘍剤

Also Published As

Publication number Publication date
PL326236A1 (en) 1998-11-23
EP0877022B1 (de) 2003-04-16
HRP970239B1 (en) 2004-04-30
CA2237267A1 (en) 1998-11-09
CZ142498A3 (cs) 1999-08-11
HRP970239A2 (en) 1999-02-28
EP0877022A1 (de) 1998-11-11
ATE237594T1 (de) 2003-05-15
DE69813362T2 (de) 2004-04-01

Similar Documents

Publication Publication Date Title
DE69813362D1 (de) Sulfonylpyrimidine Derivate mit Antitumor Wirkung
FI932032A (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
TR199800012T1 (xx) Piroloprimidinler ve preparasyon i�in tatbikler.
DE9290018U1 (de) 2,4-Diaminochinazolin-Derivate zur Verbesserung der Antitumor-Aktivität
DE69710490T2 (de) Triazolo(4,5-d)pyrimidinyl-derivate und ihre verwendung als medikamente
TR199801755T2 (xx) Pirimido(5,4-D)pirimidinler, bu bile�ikleri i�eren farmas�tik maddeler.
IL117923A0 (en) Pyrido [2,3-d] pyrimidine derivatives and pharmaceutical compositions containing them
ATE199906T1 (de) Phosphonat-nukleotid ester-derivate
AU7533091A (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
IT1297080B1 (it) Composizione per il trattamento di ustioni, eritemi solari, abrasioni, piaghe e irritazioni cutanee
ATE119157T1 (de) Pyrimidinderivate zur erhöhung der antitumoraktivität.
AU586043B2 (en) Imidazo``1,5-a``quinazoline derivatives, their preparation and use.
DE58904434D1 (de) Organische derivate von rheniumoxiden sowie ihre herstellung und verwendung zur metathese von olefinen.
DE69812177T2 (de) 3'-epi k-252a derivate
ATE61590T1 (de) Rhizoxinderivate, ihre herstellung und pharmazeutische verwendung.
DK478485D0 (da) 4-oxo-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse
SE8902340D0 (sv) Mitomycin phosphate derivatives
IT1313593B1 (it) Derivati di 1,2-diidro-1-oxo-pirazino 1,2-a indolo.
DK522187D0 (da) Imidozothienopyrimidiner, deres fremstilling og anvendelse
ES2051722T3 (es) Procedimiento para estabilizar derivados de procaterol.
GR920100523A (el) Ενώσεις.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: RUDER BOSKOVIC INSTITUTE, ZAGREB, HR

8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOZYNE D.O.O., ZAGREB, HR